Andrew J. Dalley

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution

Jason A. Roberts, Carl M. J. Kirkpatrick, Michael S. Roberts et al. · Journal of Antimicrobial Chemotherapy · 2009 · 348 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Epithelial to mesenchymal transition (EMT) biomarkers – E-cadherin, beta-catenin, APC and Vimentin – in oral squamous cell carcinogenesis and transformation

S.Y. Chaw, Ahmad Abdul Majeed, Andrew J. Dalley et al. · Oral Oncology · 2012 · 311 citations

Medicine, Cancer Biology, Oncology +16

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis

Jason A. Roberts, Carl M. J. Kirkpatrick, Michael S. Roberts et al. · International Journal of Antimicrobial Agents · 2009 · 195 citations

Medicine, Pharmacokinetics, Pharmacology +16

Piperacillin penetration into tissue of critically ill patients with sepsis—Bolus versus continuous administration?

Jason A. Roberts, Michael S. Roberts, Thomas A. Robertson et al. · Critical Care Medicine · 2009 · 181 citations

Medicine, Pharmacokinetics, Pharmacology +17

Urinary and serum type II collagen: markers of renal fibrosis

Oğuz Söylemezoğlu, G. Wild, Andrew J. Dalley et al. · Nephrology Dialysis Transplantation · 1997 · 109 citations

Medicine, Nephrology, Pathology +15